With a holistic approach, well look at the full picture of your health concernsfrom weight management to gut health and moreand address the root cause of your symptoms
"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept." Cell Metabolism
doi:10.3928/01477447-20151222-12 Carender CN, Glass NA, DeMik DE, Elkins JM, Brown TS, Bedard NA
In contrast, when the concentration of carnitine in the plasma increases and the filtration load of carnitine increases, the kidney rapidly increases the rate of carnitine excretion and reduces its reabsorption efficiency to prevent the excessive accumulation of carnitine in the body
Leonard Glass, senior vice president of global medical affairs at Lilly Cardiometabolic Health, said in the news release
Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
